Servatus Biopharmaceuticals

About:

Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases.

Website: https://www.servatus.com.au

Top Investors: Melbourne Angels

Description:

Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases - utilising their proprietary technology. They are engineering "intelligent" directed changes into the structure of select proteins to improve their clinical utility.

Total Funding Amount:

7.5M AUD

Headquarters Location:

Sippy Downs, Queensland, Australia

Founded Date:

2012-01-01

Contact Email:

invest(AT)servatus.com.au

Founders:

Wayne Finlayson, Wolf Hanisch

Number of Employees:

1-10

Last Funding Date:

2021-12-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai